Discover the detailed record of transactions filed by 이준행. Officer active across 1 companies, notably 박셀바이오. Cumulatively, 12 filings have been published. Regulator: DART (FSS). All data is openly available.
Declarations 12 total
● Executives · 31 May 2024 · 박셀바이오 637,961 shares DART:20240531002827 ● Executives · 21 May 2024 · 박셀바이오 2,015,877 shares DART:20240521000219 Ideal exit: 15 Feb 2025 (T+270) ● Executives · 21 May 2024 · 박셀바이오 2,015,877 shares DART:20240521000226 Ideal exit: 15 Feb 2025 (T+270) ● Executives · 13 May 2024 · 박셀바이오 2,015,877 shares DART:20240513000016 Ideal exit: 7 Feb 2025 (T+270) ● Executives · 10 May 2024 · 박셀바이오 2,015,877 shares DART:20240510001055 Ideal exit: 4 Feb 2025 (T+270) ● Executives · 17 Nov 2023 · 박셀바이오 2,015,877 shares DART:20231117000117 Ideal exit: 13 Aug 2024 (T+270) ● Executives · 31 Oct 2023 · 박셀바이오 2,015,877 shares DART:20231031000505 Ideal exit: 27 Jul 2024 (T+270) ● Executives · 23 Oct 2023 · 박셀바이오 2,015,877 shares DART:20231023000274 Ideal exit: 19 Jul 2024 (T+270) ● Executives · 6 Oct 2023 · 박셀바이오 2,015,877 shares DART:20231006000565 Ideal exit: 2 Jul 2024 (T+270) ● Executives · 18 Apr 2022 · 박셀바이오 2,015,877 shares DART:20220418000255 Ideal exit: 13 Jan 2023 (T+270) ● Executives · 11 Apr 2022 · 박셀바이오 2,015,877 shares DART:20220411001015 Ideal exit: 6 Jan 2023 (T+270) ● Executives · 5 Apr 2021 · 박셀바이오 2,015,877 shares DART:20210405002918 Ideal exit: 31 Dec 2021 (T+270)